Those limitation are very important and Anavex are really a bit lame with this statement comparing a failed trial with a successful one that led to approval.
Having said that, there are some things that Anavex can and likely will want to show with more analysis that could potentially help the case for an Accelerated Approval with a confirmatory trial, but chances are not great imo.